HYPOTRICHOSIS 11
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Mutations in SNRPE, which encodes a core protein of the spliceosome, cause autosomal-dominant hypotrichosis simplex.
|
23246290 |
2013 |
HYPOTRICHOSIS 11
|
0.600 |
GeneticVariation
|
disease |
UNIPROT |
Mutations in SNRPE, which encodes a core protein of the spliceosome, cause autosomal-dominant hypotrichosis simplex.
|
23246290 |
2013 |
HYPOTRICHOSIS 11
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Hereditary hypotrichosis simplex.
|
9621144 |
1998 |
HYPOTRICHOSIS 11
|
0.600 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Hypotrichosis
|
0.400 |
Biomarker
|
disease |
HPO |
|
|
|
Hypotrichosis
|
0.400 |
Biomarker
|
disease |
CTD_human |
|
|
|
Hypotrichosis simplex
|
0.310 |
GeneticVariation
|
disease |
BEFREE |
Mutations in SNRPE, which encodes a core protein of the spliceosome, cause autosomal-dominant hypotrichosis simplex.
|
23246290 |
2013 |
Hypotrichosis simplex
|
0.310 |
GermlineCausalMutation
|
disease |
ORPHANET |
Mutations in SNRPE, which encodes a core protein of the spliceosome, cause autosomal-dominant hypotrichosis simplex.
|
23246290 |
2013 |
Lupus Nephritis
|
0.200 |
Therapeutic
|
disease |
RGD |
Intravenous injection of a D1 protein of the Smith proteins postpones murine lupus and induces type 1 regulatory T cells.
|
15494537 |
2004 |
Alopecia
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Sparse eyelashes
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Absent axillary hair
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Sparse body hair
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Hypotrichosis of the scalp
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Sparse or absent eyelashes
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Aplasia/Hypoplasia of the eyebrow
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Sparse and thin eyebrow
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Microcephaly
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Together, our study links defects in the SNRPE gene to microcephaly and suggests that alterations of cellular splicing of specific mRNAs such as EMX2 results in the neurological phenotype of the disease.
|
31671093 |
2019 |
Congenital microcephaly
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Here we report the identification of a de novo heterozygous missense mutation in the SNRPE gene (c.65T>C (p.Phe22Ser)) in a patient with non-syndromal primary (congenital) microcephaly and intellectual disability.
|
31671093 |
2019 |
Intellectual Disability
|
0.010 |
GeneticVariation
|
group |
BEFREE |
Here we report the identification of a de novo heterozygous missense mutation in the SNRPE gene (c.65T>C (p.Phe22Ser)) in a patient with non-syndromal primary (congenital) microcephaly and intellectual disability.
|
31671093 |
2019 |
Neoplasms
|
0.010 |
Biomarker
|
group |
BEFREE |
One novel tumor suppressor (tripartite motif-containing 35 [TRIM35]) and two putative oncogenes (hairy/enhancer-of-split related with YRPW motif 1 [HEY1] and small nuclear ribonucleoprotein polypeptide E [SNRPE]) were discovered by various in vitro and in vivo tumorigenicity experiments.
|
21688285 |
2011 |
Fibrosarcoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Dose-dependent suppressions of MMPs and TIMP-2 mRNA levels were observed in SME-6-treated HT1080 human fibrosarcoma cells detected by reverse transcriptase-polymerase chain reaction.
|
16309669 |
2005 |
Adult Fibrosarcoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Dose-dependent suppressions of MMPs and TIMP-2 mRNA levels were observed in SME-6-treated HT1080 human fibrosarcoma cells detected by reverse transcriptase-polymerase chain reaction.
|
16309669 |
2005 |
Tumor Cell Invasion
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
Furthermore, SME-6 inhibited the invasion, motility, and migration of tumor cells.
|
16309669 |
2005 |